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Dr Valavanur Subramanian (New York, NY). Very elegant.
I have a few questions. How do you adjust your amount
of folding into your clip or do you have different sizes, number
one?
Dr Feins.We have multiple clip sizes that we use. For the pur-
poses of this in vivo study, we found that almost all animals except
1 required just the smallest size clip we have, which I can back up790 The Journal of Thoracic and Cardiovascular Surgto show you based on the scale from my slides. One animal did
require a larger clip.
The clips themselves are fairly fixed in the amount of leaflet
tissue that they can plicate, which you can see is probably defined
by the maximum opening state of the clip itself. However, it is a
fairly trivial matter to create variable size clips for the purposes
of plicating different amounts of leaflet tissue.
Dr Subramanian. In the animals, do you look at the flailed gap,
howmuch of a flailed gap you had before you had a successful clip
deployment?
Dr Feins. I’m sorry, could you repeat the question?
Dr Subramanian. The flailed gap, how much of a prolapse
from the annular plane, because there are limitations there.
Dr Feins.What we had tried to dowasmaintain the chordae that
were supporting the segments of the leaflet between the P2 and P3
scallops and the P1 and P2 scallops, with the goal of having some
leaflet tissue of P2 that still had chordal support so that when we
plicated the central segment we would have some supporting
leaflet tissue to maintain valve function.
Generally speaking, our goal was to create prolapse in just the
central portion of P2, which essentially was about 3 or 4 mm.
I would say between 3 and 5 mm in terms of the length of the
coaptation line for the valve itself.
Dr Song Wan (Shatin, Hong Kong). Congratulations for this
innovative design and excellent experimental result. I have one
comment and one question. The comment is, your idea appears
to me to be more advanced than MitraClip, however, it didn’t
overcome the intrinsic critical drawback of MitraClip, namely, it
only addresses the leaflet but not the annulus, and without proper
annuloplasty, the long-term durability is reduced, as all of us know
already.
The question is, your device seems more suitable for the
chronic, for example, P2 prolapse, with excessive valve tissue
and maybe myxomatous change. However, your animal model is
an acute model with chordal cutting, and the leaflets are more or
less normal in this setting. Do you think your device can be used
in acute MR, like a sudden rupture of the chordae, exactly mimic
your animal model?
DrFeins.Thank you for your comments and question. I certainly
think that there is some limitation to our animalmodel with regard to
the type of lesion that wewere creating. Not all prolapses are created
equal, and this is a very different lesion than a myxomatous valve
with excessive leaflet tissue. This is a limitation of our model.
You could envision various scenarios where you would create a
more clinically similar type of lesion, and that may involve
augmentation of the leaflet and then surviving animals to create a
dilated annulus that mimics the clinical scenario.
The purposes of this study were mainly to assess the clip in an
acute setting, not because this would necessarily be a replacement
to a chordal replacement, for example, but simply as a way of
seeing if the ex vivo findings that we had could be reproducible
in an acute model. And I suspect in the setting of what you are
describing, which is excessive leaflet tissue with redundancy,
which we see in a more chronic setting, that this leaflet plication
clip would arguably have even better results than in an acute
chordal rupture model.
And just in response to your comment, I completely agree. Our
intention for not including an annuloplasty was simply to assessery c February 2014
Feins et al Evolving Technology/Basic Sciencethe sole effect of the clip in isolation. I think we can all agree that
an annuloplasty in addition will improve outcomes. And while
the clip doesn’t add an annuloplasty, and in that way is not an
improvement on the current MitraClip, I think it is fair to say
that one of the reasons that mitral valve reparative surgery has
improved over the past several decades is due to the breadth of
reparative techniques we have: annuloplasty, edge-to-edge repair,
and the various ways to address the leaflet and the chordae. This
represents one way of doing that by plicating the leaflet rather
than simply involving the other leaflet segments.The Journal of Thoracic and CaDrMathewWilliams (New York, NY). What are your plans for
putting this in a catheter-based approach?
Dr Feins. We are currently developing some of the minimally
invasive methods for implanting this, and there is a wide range
of applications. I think when we developed this, we saw this not
just as a percutaneous or catheter-based technique. There are
also transcardiac ways of implanting it, as well as implantation
in the open heart. One could argue that in conventional heart sur-
gery, having a device such as this allows for a more reproducible
way of plicating the leaflet instead of suture-based techniques.rdiovascular Surgery c Volume 147, Number 2 791
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